HomeCompareRHHVF vs SBUX

RHHVF vs SBUX: Dividend Comparison 2026

RHHVF yields 3.09% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBUX wins by $124.8K in total portfolio value
10 years
RHHVF
RHHVF
● Live price
3.09%
Share price
$403.29
Annual div
$12.47
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.7K
Annual income
$2,296.61
Full RHHVF calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — RHHVF vs SBUX

📍 SBUX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRHHVFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RHHVF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RHHVF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RHHVF
Annual income on $10K today (after 15% tax)
$262.77/yr
After 10yr DRIP, annual income (after tax)
$1,952.12/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, SBUX beats the other by $54,011.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RHHVF + SBUX for your $10,000?

RHHVF: 50%SBUX: 50%
100% SBUX50/50100% RHHVF
Portfolio after 10yr
$95.1K
Annual income
$34,068.36/yr
Blended yield
35.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

RHHVF
Analyst Ratings
3
Buy
5
Hold
1
Sell
Consensus: Hold
Altman Z
5.5
Piotroski
7/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RHHVF buys
0
SBUX buys
0
No recent congressional trades found for RHHVF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRHHVFSBUX
Forward yield3.09%2.75%
Annual dividend / share$12.47$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR17%48.3%
Portfolio after 10y$32.7K$157.5K
Annual income after 10y$2,296.61$65,840.13
Total dividends collected$10.5K$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusHoldBuy

Year-by-year: RHHVF vs SBUX ($10,000, DRIP)

YearRHHVF PortfolioRHHVF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$11,062$361.70$11,107$407.21$45.00SBUX
2$12,274$437.50$12,512$626.87$238.00SBUX
3$13,663$530.79$14,366$978.69$703.00SBUX
4$15,266$646.13$16,929$1,557.50$1.7KSBUX
5$17,124$789.38$20,658$2,543.80$3.5KSBUX
6$19,291$968.20$26,406$4,302.22$7.1KSBUX
7$21,834$1,192.66$35,877$7,622.00$14.0KSBUX
8$24,838$1,476.03$52,741$14,352.64$27.9KSBUX
9$28,413$1,836.07$85,676$29,243.03$57.3KSBUX
10$32,699$2,296.61$157,513$65,840.13$124.8KSBUX

RHHVF vs SBUX: Complete Analysis 2026

RHHVFStock

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.

Full RHHVF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this RHHVF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RHHVF vs SCHDRHHVF vs JEPIRHHVF vs ORHHVF vs KORHHVF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.